Most telehealth providers offer compounded tirzepatide only as an injection. Oral options—sublingual tablets, lozenges, capsules—exist but remain the minority. This evidence-based comparison shows which platforms offer which route, at what price, and where the economics and logistics differ in 2026.

Henry Meds sells tirzepatide only as an oral dissolving tablet, with a 3-month prepaid plan priced at $297/month ($891 total). Injectable tirzepatide is not offered. PlexusDx injectable tirzepatide runs $289/month month-to-month or $249/month on a 6-month plan.

We compare verified pricing, service quality, and value for compounded oral tirzepatide programs from PlexusDx, Henry Meds, MEDVi, Eden, and ShedRx using captured checkout data and Trustpilot ratings through September 2026.

Henry Meds and Eden both offer compounded semaglutide and tirzepatide in oral and injectable forms, but billing structures, month-to-month rates, and all-in costs differ substantially.

Henry Meds is the only competitor in our evidence offering oral tirzepatide tablets at $891 for 3 months (no month-to-month rate captured). PlexusDx oral tirzepatide is $349/month with no membership fee, cancel anytime.

Weekly GLP-1 injections offer a structured once-per-week treatment routine, while daily ODTs provide a needle-free option for patients who prefer an oral dissolving tablet. Understanding the difference helps you choose the semaglutide or tirzepatide format that best fits your goals, lifestyle, and consistency.

The standard FDA tirzepatide dosing schedule moves through six weekly dose levels: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg, with at least four weeks between steps. This guide walks the week-by-week ladder for both injection and oral compounded tirzepatide, the milligram-to-unit conversions for compounded vials, missed-dose rules, and how the GIPR rs1800437 genetic variant can inform titration pace before week one.

An honest, verified review of Skinny Rx tirzepatide tablets — the $299/month buccal-dissolve compounded product, the February 2026 FDA warning letter, and the actual evidence picture for any oral tirzepatide formulation — with a feature-by-feature comparison to PlexusDx Tirzepatide Oral Protocol ($349/mo, 5mg to 25mg daily across seven dose levels) as the cash-pay alternative.

Is oral tirzepatide FDA approved? No — only injectable Mounjaro and Zepbound are. Here's what compounded oral tirzepatide is, how PlexusDx Tirzepatide Oral ($349/mo) fits, and the safety considerations that apply to both.